AbbVie Stock Post Humira is Still an Attractive Stock to Hold
MarketBeatAbbVie’s strategic diversification and strong financial position make it possible to sustain growth despite the perceived “Humira cliff.”
AbbVie’s strategic diversification and strong financial position make it possible to sustain growth despite the perceived “Humira cliff.”